Greetings!

It's nice to be back! Our first speaker is our own Dr. Liberty Hamilton on October 19th. It's a longer period to give our speaker some more time as well as ample time for interactive discussion. We'll have some nice refreshments there.

Through Mechanical Engineering, I'm hosting a rehabilitation robotics speaker, Jim Schmiedeler, on 10/12.

Are you a clinician or a person with an injury that limits your abilities who wants to get involved in CARE but can't make it to campus? Please contact me.

Best,

James Sulzer

Assistant Professor, Mechanical Engineering

Interested in having a more intimate discussion with Dr. Hamilton about her research and career? Want to ask her questions relevant to your own career? Hungry?

Time: 12 p.m. - 1 p.m.

Place: SEA 4.242

Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)

(RFA-NS-18-043 –  https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-043.html )

Multiple Institutes

Application Receipt Date(s): November 27, 2018; February 11, 2019; July 11, 2019; November 12, 2019. 

• Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)

(RFA-NS-18-046 –  https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-046.html )

Multiple Institutes

Application Receipt Date(s): November 27, 2018; March 7, 2019; November 25, 2019; March 12, 2020. 

• Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) Coordinating Center: Synergizing Career Development toward Improved Care of Older Adults across Specialties and Disciplines (U24 - Clinical Trial Optional)

(RFA-AG-19-024 –  https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-024.html )

National Institute on Aging

Application Receipt Date(s): February 4, 2019. 

• NIH Administrative Supplements to Recover Losses Due to Hurricanes Harvey, Irma, and Maria Under the Bipartisan Budget Act of 2018 Non-Construction (Admin Supp Clinical Trial Optional)

(PA-18-936 –  https://grants.nih.gov/grants/guide/pa-files/PA-18-936.html ) 

Multiple Institutes

Application Receipt/Submission Date(s): December 14, 2018. 

• Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional)

(PA-18-937 –  https://grants.nih.gov/grants/guide/pa-files/PA-18-937.html ) 

Multiple Institutes

Application Receipt/Submission Date(s): Standard dates. 

• Research on Chronic Overlapping Pain Conditions (R21 Clinical Trial Not Allowed)

(PA-18-939 –  https://grants.nih.gov/grants/guide/pa-files/PA-18-939.html ) 

Multiple Institutes

Application Receipt/Submission Date(s): Standard dates apply. 

• Clinical and Translational Science Award (U54 Clinical Trial Optional)

(PAR-18-940 –  https://grants.nih.gov/grants/guide/pa-files/PAR-18-940.html ) 

National Center for Advancing Translational Sciences

Application Receipt/Submission Date(s): January 25, 2019, April 15, 2019, August 15, 2019, December 16, 2019, April 15, 2020, August 17, 2020, December 15, 2020, April 15, 2021, August 15, 2021. 

• Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Optional)

(PAR-18-941 –  https://grants.nih.gov/grants/guide/pa-files/PAR-18-941.html ) 

National Institute of Mental Health

Application Receipt/Submission Date(s): November 26, 2018. 

• Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Optional)

(PAR-18-942 –  https://grants.nih.gov/grants/guide/pa-files/PAR-18-942.html ) 

National Institute of Mental Health

Application Receipt/Submission Date(s): November 26, 2018. 

• Development Innovation Ventures (DIV) is Accepting New Applications! Do you have a breakthrough idea to solve a global development problem? USAID wants to hear from you! USAID's open innovation program - Development Innovation Ventures (DIV) - is accepting new applications to test and scale creative solutions to any global development challenge. Anyone, anywhere can apply at any time. DIV provides tiered grant funding (from $50,000 to $5,000,000) to test new ideas and scale the best solutions that demonstrate rigorous evidence of impact, cost-effectiveness, and a viable pathway to scale. For more information and how to apply, please visit:  https://www.usaid.gov/div  

• MR3 Network Opportunities

o TREAT has a two-phase application procedure for pilot grants. Abstracts are reviewed on a revolving basis to determine if the product falls within TREAT‘s expertise and mission. If accepted, applicants are then asked to complete a more comprehensive proposal that will be assessed by a multidisciplinary panel of technical, business, and clinical experts during one of our triannual review sessions.

Abstract: January 8, 2019

Proposal: January 22, 2019 

Apply:  http://treatcenter.org/application/